Suriname vs Tajikistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Suriname
0.2%
in 2024
Tajikistan
0.2%
in 2024
Suriname rank
98th
Tajikistan rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Suriname
- Tajikistan
How they compare
Suriname currently reports 0.2% against 0.2% in Tajikistan, a difference of 0.0%.
Across all 10 years both countries report, Tajikistan has been ahead every year.
Suriname ranks 98th and Tajikistan ranks 98th of 246 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Suriname | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Tajikistan |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Suriname or Tajikistan?
- Suriname, at 0.2% against 0.2% in Tajikistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Suriname and Tajikistan?
- 0.0%, with Suriname ahead.
- How many years of comparable data are there for Suriname and Tajikistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Suriname and Tajikistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Suriname ranks 98th and Tajikistan ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.